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INTRODUCTION

The secret to fame and importance in American society is often the
ability to crossover into mainstream media and maintain a continuing
presence. If that is the case, meet America's new rising stars: human
embryonic stem cells. Once limited to the pages of Science, Nature, and
other scientific journals, human embryonic stem cells now find
themselves center stage in American politics. The death of former
President Ronald Reagan from Alzheimer's disease in June 2004 and
the death of Superman himself, Christopher Reeve, in October 2004, as
well as the Bush-Kerry Presidential election have caused people all
across America to discuss the scientific and ethical aspects of human
embryonic stem cell research and therapeutic cloning. From President
George W. Bush to Howard Stem, from the New York Times to People
Magazine, human embryonic stem cells have America's attention.
Because human embryonic stem cell research and therapeutic
cloning are so controversial, this note advocates that the United States
should adopt a similar legal approach as the United Kingdom. The U.K.
has decided the potential benefits that will result from human embryonic
stem cell research outweigh the ethical problems. The promise of
potential benefits has prompted the U.K. to provide public funds for
both areas of research and, therefore, the British government is better
able to monitor and regulate both procedures. The U.S., on the other
hand, has banned public funding for human embryonic stem cell
research and therapeutic cloning, but it has left private research largely
unregulated. The U.S. government needs to increase public spending
and impose more restrictions on human embryonic stem cell research
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and therapeutic cloning to prevent U.S. scientists from developing
projects that go beyond what the public and legislators will be able to
tolerate. If the citizenry's bounds of decency continue to be pushed by
controversial genetic research, there is a risk that all types of human
embryonic stem cell research and therapeutic cloning will be banned.
Without public funding and regulation, therefore, the U.S. will be
unable to fully realize the potential benefits of these two types of
research.
Part I of this note evaluates human embryonic stem cell research,
including an explanation of the potential benefits of this procedure and
the ethical debates surrounding this type of research. Part I also
identifies the legal approach to human embryonic stem cell research
currently used in the U.S. Next, Part I addresses therapeutic cloning.
First, therapeutic cloning is explained and then distinguished from
reproductive cloning. Second, Part I discusses the ethical concerns that
arise from therapeutic cloning. Third, Part I outlines the current U.S.
legal approach to therapeutic cloning. Part II of this note explains the
British approach to both of these controversial research procedures. Part
III describes the state of unregulated, private genetic research in the
U.S. Finally, Part IV proposes that the U.S. adopt a legal scheme
similar to that in Britain regarding human embryonic stem cell research
and therapeutic cloning.
I.

EVALUATION OF HUMAN EMBRYONIC STEM CELL RESEARCH

Human embryonic stem cells have the potential to develop into
many different cell types in the body. 1 The three classes of human stem
cells are totipotent, multipotent, and pluripotent. 2 A fertilized egg is
totipotent because it has reached its total potential and can develop into
all different types of cells in the body. 3 Multipotent cells, meanwhile,
are human stem cells that can develop into a small number of different
cells in the body. 4 Finally, pluripotent human stem cells can develop
into any type of cell but they cannot give rise to those cells needed to
develop a fetus. 5
Scientists believe that human embryonic stem cells have much
greater developmental potential than adult stem cells because embryonic

1. National Institute of Health, Stem Cell Information: Frequently Asked Question, at
http://stemcells.nih.gov/info/faqs.asp (last visited Nov. 13, 2004).
2. Id.
3. Id.
4. Id.
5. Id.
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stem cells are thought to be pluripotent, while adult cells are thought to
be multipotent. 6 Pluripotent stem cells are derived from either human
embryos that are a few days old, called blastocysts, or from fetal tissue
obtained from terminated pregnancies. 7 Stem cells derived from
blastocysts or from fetal tissue are then used to cultivate stem cell lines. 8
Most stem cells originate from surplus embryos that were created for
infertility research purposes from in vitro fertilization procedures. 9
These stem cells are then offered to scientists after a donor's informed
consent is obtained. Io It is important to highlight that human embryonic
stem cells are not taken from eggs fertilized in a woman's body. I I
These embryonic stem cell lines are essential for researchers
because they are essentially immortal. I 2 Once a cell line is established,
unlimited cells can be created and then frozen for storage or distribution
to other researchers. I 3 Human embryonic stem cell lines developed in a
laboratory are called cell cultures. I 4 The cells divide and spread over a
culture dish. Is When the cells begin to outgrow the dish, researchers
then rep late the cells. I 6 This process of relocating the cells into different
plates is repeated for about six months and, at the end of this period,
scientists use the healthy cells to establish a stem cell line. I 7 A scientist
can start with 30 original cells and end up with millions. I 8 If the cells
were not replated, they would clump together and form heart blood
cells, muscle cells, nerve cells, or many other types of cells. I 9
A.

Potential Benefits of Human Embryonic Stem Cells

Human stem cell lines are a vital resource for scientists because of
their potential use in transplantation and treatment of diseases, screening
new drugs, and understanding birth defects. 2 For instance, researchers

°

6. National Institute of Health, supra note 1.
7. Id.; National Institute of Health, Stem Cell Information: Stem Cell Basics,
http://stemcells.nih.gov/info/basics/basics3.asp (last visited Aug. 20, 2004).
8. National Institute of Health, supra note 1; National Institute of Health, supra note 7.
9. National Institute of Health, supra note 7.
10. Id.
11. Id.
12. Id.
13. Id.
14. National Institute of Health, supra note 7.
15. Id.
16. Id.
17. Id.
18. Id.
19. National Institute of Health, supra note 7.
20. Id.
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point to the problems that currently face doctors when transplanting
organs in a patient. 21 Doctors must overcome complications caused by
the rejection of the new organ by a patient's immune system. 22
Researchers believe that human embryonic stem cell lines will be able
to overcome this immune rejection in the future through gene therapy. 23
Currently, scientists are trying to overcome the technical challenges of
how to control the evolution of pluripotent cells into specific cells in the
body because scientists want these cells when they are at an initial and
undefined stage. Another challenge faced by researchers is the danger
that a patient's body could reject foreign, donor embryonic stem cells. 24
Human embryonic stem cells may also be used to test new drugs. 25
The benefit of using pluripotent cell lines is that drugs could be tested in
a wider range of cell types. 26 Again, the problem researchers face is how
to control the development of these pluripotent cells into different cells
in the body. 27
In addition, human embryonic stem cells may prove invaluable to
the treatment of some of the gravest medical conditions, such as cancer
and birth defects, caused by abnormal cell division. 28 Once researchers
understand what causes a human embryonic stem cell to evolve into a
specific type of cell (i.e., muscle cell or nerve cell), then it may be
possible to prevent abnormal cells from developing. 29
Scientists estimate that human embryonic stem cells will make the
greatest impact in regards to the generation of cells and tissues. 30
Donated organs and tissues are used to repair bad tissue, but the demand
for new tissues and organs far outweigh the supply. 31 Researchers
believe that human embryonic stem cells will become a renewable
source of replacement and will be used to treat Parkinson's disease,
Alzheimer's disease, spinal cord injuries, strokes, burns, heart disease,
diabetes, and various forms of arthritis. 32

21. National Institute of Health, supra note 7.
22. Id.
23. Id.
24. Id.
25. Id.
26. National Institute of Health, supra note 7.
27. Id.
28. Id.
29. Id.
30. Id.
31. National Institute of Health, supra note 7.
32. Id.; see also, Cynthia Donley Young, Comment: A Comparative Look at the U.S.
and British Approaches to Stem Cell Research, 65 ALB. L. R.Ev. 830, 833 (2002).
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Differences between Adu# Stem Cells and Embryonic Stem Cells

The U.S. government permits testing on adult stem cells, which
have turned out to be more useful than researchers initially thought. 33
There are, however, several important limitations regarding the use of
these multipotent cells. Adult stem cells are often found ·only in small
quantities and, therefore, it is difficult to isolate and purify these cells. 34
Also, there is evidence that adult cells have a lesser capacity than
embryonic stem cells to multiply. 35 Researchers have been unsuccessful
so far in creating an adult stem cell culture, and since large numbers of
cells are required for stem cell replacement therapies, this is an
important difference between adult and embryonic cells. 36 Lastly, "adult
stem cells may contain more DNA abnormalities--caused by sunlight,
toxins and errors in making more DNA copies during the course of a
lifetime."37 Consequently, researchers believe adult stem cells have a
more limited application than embryonic stem cells. 38
In addition, the primary role of adult stem cells differs from that of
embryonic stem cells. 39 Adult cells work within the body to maintain
and repair the tissue in which they are located. 40 Adult stem cells are
believed to reside in a specific area of a tissue where they do not divide
until division is triggered by disease or tissue damage. 41 The adult
tissues that contain stem cells include the brain, blood, skeletal muscles,
skin, and liver. 42 Thus, the potential use of adult stem cells may be
restricted because they become cell types of their tissue of origin. 43 On
the other hand, embryonic stem cells can give rise to all different types
of tissue in the body. 44

33. National Institute of Health, supra note 7.
34. Denise Stevens, Comment: Embryonic Stem Cell Research: Will President Bush's
Limitation on Federal Funding Put the United States at a Disadvantage? A Comparison
between U.S. and International Law, 25 Rous. J. INT'L L. 623, 632 (2003).
35. National Institute of Health, supra note 7.
36. Id.
37. Id.
38. Id.
39. Id.
40. National Institute of Health, supra note 7.
41. Id.
42. Id.
43. Id.
44. Id.
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Ethical Concerns Regarding Human Embryonic Stem Cell
Research

Although the potential benefits of embryonic stem cell research
seem to outweigh the use of adult stem cells, the U.S. has failed to
embrace this line of research because of the ethical concerns associated
with the destruction of embryos. 45
Some opponents of human
embryonic stem cell research argue that the moral status of a person
begins at conception. 46 Since embryos are destroyed in the process,
these opponents assert this type of research is immoral because a person
or potential person is being denied life without due process of U.S.
laws. 47 Furthermore, a person or potential person is being denied the
proper level of respect embodied within the United Nations Declaration
on Human Rights. 48 That Declaration provides that "everyone has a
right to life, liberty and security of person. " 49
Also, opponents are concerned that doctors and women will work
together to create embryos for the sole purpose of establishing a supply
of stem cells. 50 This concern is heightened when a donor or doctor may
have a relationship with a patient who could potentially benefit from
human embryonic stem cell research. 51 For example, suppose that a
doctor has a parent who is suffering from Parkinson's disease. This
doctor has been doing extensive research and believes that embryonic
stem cells are the solution to this terrible ailment. Suddenly, a woman
enters the doctor's office and wants to discuss the termination of her
pregnancy. The doctor chooses to make a more persuasive argument in
favor of terminating the pregnancy and the woman follows this advice.
Another argument against the use of embryonic cells is that of antiabortion activists. 52 They are concerned that the process of extracting
cells from aborted fetuses will allow researchers to use fetal tissue and
thus sway otherwise undecided women to pursue an abortion, by
providing an argument in support of abortion. 53 Consequently,
opponents of abortion are concerned that women will justify their
decisions to terminate their pregnancies because the cells may make a

45 . Young, supra note 32, at 834.
46. Id. at 835 .
47. Id.
48. James J. McCartney, Essay: Embryonic Stem Cell Research and Respect for
Human Life: Philosophical and Legal Reflections, 65 ALB.L REv. 597, 602 (2002).
49. Id.
50. Young, supra note 32, at 836.
51. Id.
52. Id. at 836-37.
53. Id. at 836.
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positive contribution to medical research. 54 Similarly, women may be
even more likely to justify their decisions to terminate pregnancies
when they know people who are ill and may be helped by human
embryonic stem cell research. 55
Proponents of stem cell research, however, disagree that the human
embryo deserves the legal status due a fully formed human being. 56
Moreover, these same proponents believe that it would be immoral not
to use embryos that would otherwise be destroyed since embryonic stem
cells have the potential to cure and treat millions of Americans who are
plagued by various health problems. 57 Furthermore, supporters of stem
cell research assert that human embryonic stem cells derived from
surplus embryos under in vitro fertilization procedures do not fit the
technical definition of an embryo. 58 The is so because embryonic stem
cells "do not have the capacity to develop into a human being even if
transferred to the uterus, thus, their destruction in the course of research
would not constitute the destruction of an embryo."59
Moreover, advocates of human embryonic stem cell research state
that it is unlikely that "women contemplating abortion would be swayed
by research. " 60 In addition, lawmakers have taken steps to further
insulate women from making pregnancy decisions based on sick family
members and friends. 61 Laws prohibit women from designating a
recipient of their embryonic cells. 62
D.

U.S. Legal Approach to Human Embryonic Stem Cell Research

The cloud of controversy that cloaks embryonic stem cell research,
coupled with the unknown potential of these cells, has prevented the
U.S. from formulating a consistent regulatory scheme. 63 While there are
a few laws that affect government-funded research, private research, for
the most part, has been left unregulated. 64 The Food and Drug
Administration (FDA) has also been silent on what kind of restrictions

54. Id. at 836-37.
55. Young, supra note 32.
56. National Human Genome Research Institute, Cloning/Embryonic Stem Cells,
http://www.genome.gov/10004765 (last visited Nov 13, 2004)~
57. Id.
58. Id.
59. Id.
60. Id.
61. Young, supra note 32, at 837.
62. Id.
63. Id. at 841.
64. Id.
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should govern this research and states have passed laws that are both
inconsistent and vague. 65 The problem may be that legislators lack the
expertise to draft laws that capture the nuances of this area of research. 66
Terms like "embryo," "fertilization," and "cloning" need to be
specifically defined. The laws of three different States that govern
embryos have been found unconstitutional because they were too vague
and did not provide proper notice to scientists on what conduct was
regulated. 67
As the field of human embryonic stem cell research advances and
human clinical trials become a reality, the U.S. government will no
longer have the luxury of a hands-off approach. 68 Federal funding of
embryonic stem research is regulated through the Omnibus
Consolidated and Emergency Supplemental Appropriations Act, which
is an appropriations bill for the Department of Health and Human
Services (DHHS). 69 This rider prohibits public funds from being used in
research where embryos are destroyed or subjected to risk of inj~ that
is greater than the risk for research performed on fetuses in utero. 0 The
DHHS excludes research on stem cell lines because they are not
considered organisms under the statutory definition. 71 As mentioned,
these human embryonic stem cells do not have the capacity to form a
human being even if they were transferred to a woman's uterus. 72
Federal laws also regulate government-sponsored research
involving fetal tissue. 73 Fetal tissue taken from terminated pregnancies
can be used for therapeutic purposes as long as the donor's informed
consent is obtained in accordance with 42 U.S.C. § 289g-l(b)(l). 74

65. Young, supra note 32; Letter from Bernard A. Schwetz, Acting Prinipal Deputy
Commissioner Food and Drug Administration, to The Honorable Edward M. Kennedy,
Senator, Stem Cells (Sept. 5, 2001), at http://www.fda.gov/oc/stemcells/kennedyltr.html
(last visited Nov. 13, 2003).
66. Young, supra note 32, at 842.
67. Id. For a full discussion of state laws regulating embryonic stem cell research and
therapeutic cloning, see Lori B. Andrews, Legislators as Lobbyists: Proposed State
Regulation of Embryonic Stem Cell Research, Therapeutic Cloning and Reproductive
Cloning, The President's Council on Bioethics Washington, D.C. (January 2004), available
at http://www.bioethics.gov/reports/stemcell/appendix_e.htrnl (last visited on Nov. 13,
2004).
68. Young, supra note 32, at 841.
69. Id. at 843-44.
70. Id. at 844.
71. Id.; see also National Human Genome Research Institute, supra note 56.
72. Young, supra note 32, at 844; see also National Human Genome Research Institute,
supra note 57.
73. Young, supra note 32, at 845.
74. 42 U.S.C. §§ 289g-l(b)-(c) (2004); Young, supra note 32, at 845.
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Consent must be in writing and the donor must be unaware of the
identity of the tissue recipient. 75 The doctor must also submit a signed
written statement that ensures the donor consented to the abortion and
that the procedure was not impacted in any way by the potential for that
fetus to facilitate future medical study. 76 In addition, the researcher who
utilizes the fetal tissue must submit a written statement that he or she is
aware that the tissue was extracted from an aborted fetus. Finally, that
researcher must also indicate that she or he accepts the additional
responsibilities attached to research procedures that involve fetal tissue
and human embryonic cells. 77
There are additional restrictions. For example, 42 U.S.C. 289g-2
prohibits the purchase of fetal tissue when interstate commerce is
implicated. 78 Furthermore, each step must also be carried out in
accordance with applicable state laws. 79 Violators of any of these
statutory provisions may be subject to fines or imprisonment, with a
maximum sentence of ten years in jail. 80
The scope of this federal statute, however, is narrow. 81 These
provisions govern the use of fetal tissue and embryonic stem cells
derived from either aborted or stillborn pregnancies. 82 These sections,
though, only apply to the transplantation of fetal tissue and embryonic
cells into human beings. 83 As a result, these provisions may not be
applicable to human embryonic stem cell research since testing is
limited to the stem cells themselves, and they do not provide for
transplantation of these cells into human subjects. 84 The language of
these laws, therefore, permits federal funding of human embryonic stem
cell research. The problem for researchers is that human embryonic
stem cell research is governed, not by federal law, but by the President's
policies.

75. 42 U.S.C. §§ 289g-l(b)-(c) (2004); Young, supra note 32, at 845.
76. 42 U.S.C. §§ 289g-l(b)-(c) (2004); Young, supra note 32, at 845.
77. 42 U.S.C. §§ 289g-l(b)-(c) (2004); Young, supra note 32, at 845.
78. 42 U.S.C. § 289g-2 (2004); Young, supra note 32, at 845.
79. Young, supra note 32, at 845.
80. 42 U.S.C. § 289g-2 (2004); Young, supra note 32, at 845.
81. Young, supra note 32, at 845-46.
82. Id.
83. Id.
84. Human Genome Project Information, Cloning Fact Sheet, at
http://www.oml.gov/sci/ techresources/HumanGenome/elsi/cloning.shtml (last visited on
Nov. 13, 2004).
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President Bush's Stance on Human Embryonic Stem Cell Research

President Bush's policy, announced on August 9, 2001, was an
attempt to reconcile the potential benefits of human embryonic stem cell
research with the strong moral objections regarding the destruction of
embryos. 85 President Bush decided to restrict federal funding to research
on 60 stem cells lines that were already in existence to prevent further
destruction of human embryos. 86
The President assigned the National Institute of Health (NIH) to
develop guidelines on how to allocate government money and to
develop juidelines that preserve the President's stance on the use of
embryos. 7 Federal funds, therefore, can only be used for research
where embryonic stem cells were obtained with the donor's informed
consent, from excess embryos under in vitro fertilization procedures,
and without any financial incentives to taint the donors' decisions. 88 No
federal monies may be given to research involving newly destroyed
embryos, embryos created solely for research purposes or cloned human
embryos. 89 According to a White House press release, President Bush
believes that, "[t]ederal funding of medical research on these existing
stem lines will promote the sanctity of life 'without undermining it' and
will allow scientists to explore the potential of this research to benefit
the lives of millions of people who suffer from [life-destroying]
diseases. " 90
Critics of President Bush's policy claim that he overestimated the
ability of scientists to rely on existing stem cell lines. 91 Not only are
there a lot fewer stem cell lines than first thought, but researchers
believe that many lines have been corrupted and are not useable. 92
Researchers are now awaiting whether or not "Congress will exercise its
own power and mandate new rules for embryonic stem cell research;
trumping Bush's plan and sending the NIH back to the drawing board
once more. " 93
85. White House Press Release, President George Bush, Embryonic Stem Cell
Research, at http://www.d-trends.com/Government/stemcellbush.pdf (last visited on Nov.
13, 2004); see also Scott Davison, Influencing NIH Policy over Embryonic Stem-Cell
Research: An Administrative Tug-of-War Between Congress and the President, 22 J. NAT'L
Ass'N ADMIN. L. JUDGES 405, 414-17 (2002).
86. White House Press Release, supra note 85; Davison, supra note 85.
87. White House Press Release, supra note 85; Davison, supra note 85.
88. White House Press Release, supra note 85; Davison, supra note 85.
89. White House Press Release, supra note 85.
90. Id.
91. Davison, supra note 85, at 419.
92. Id. at 419-20; Letter from Bernard A. Schwetz, supra note 65.
93. Davison, supra note 85, at 410.
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Introduction to Cloning

"Trace the lines of science, religion, ethics and politics and
eventually they will intersect at one of the most divisive issues currently
at play here: human cloning."94 Cloning is a general term used to
describe scientific procedures that make duplicates of biological
material, and, in most cases, usually involve the duplication of genes
and cells without the creation of entirely new specimens.95 Therapeutic
cloning duplicates human embryos, and then researchers extract stem
cells from the cloned embryos to cultivate the cells into organs within a
laboratory setting, away from women's uteruses. In the future,
therapeutically-cloned organs may be used to replace diseased organs in
patients or to test the effects of new drugs.
When a new specimen is created, the process is called reproductive
cloning. 96 One example is the experiment that led to the formation of
Dolly the sheep in 1996. 97 Doll~ was the result of a process referred to
as somatic cell nuclear transfer. 8 Dolly was, in fact, the genetic twin of
another adult sheep. 99 Since there are, however, so many troubling
aspects of reproductive cloning, it is important to distinguish it from
therapeutic cloning. 100

1.

Overview ofReproductive Cloning

Reproductive cloning, the process used to create Dolly, is a
procedure used to create an animal that has the same genetic makeup or
DNA as another existing animal. 101 This process involves the removal
of the nucleus of an egg and replacing it with the nucleus of a donor
adult cell. 102 The reconstructed egg is then stimulated with chemicals or
electric current to trigger cell division. 103 "Once the cloned embryo
reaches a suitable stage, it is transferred to the uterus of a female host
where it continues to develop until [its] birth." 104 Reproductive cloning
is different from sexual reproduction because sexual reproduction is the

94. Kirk Semple, UN. to Consider Whether to Ban Some, or All, Forms of Cloning of
Human Embryos, N.Y. TIMES, Nov. 3, 2003, at All.
95. National Human Genome Research Institute, supra note 56.
96. Id.
97. Id.
98. Id.
99. Id.
100. National Human Genome Research Institute, supra note 56.
101. Human Genome Project Information, supra note 84.
102. Id.
103. Id.
104. Id.
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process where an egg and sperm fuse to form a new organism. 105 In
reproductive cloning, though, there is only one parent. 106 In the case of
Dolly, it "was different because she [was] not genetically unique
[although] genetically identical to [another] six-year old ewe." 107

2. Scientific Uncertainties and Ethical Concerns Regarding
Reproductive Cloning
Scientific uncertainties and ethical concerns have made the
prospect of cloning humans very troubling, even within the scientific
community. 108 Cloning studies are performed on sheep, cows, pigs,
goats, and mice. 109 Very few of these cloning attempts have been
successful so far. 110 Cloned animals often die in utero.111 Cloned
animals that do make it through birth often suffer severe birth defects. 112
In total, more than 90% of cloning attempts fail and more than 100
experiments can be required to produce one viable offspring. 113 In
addition, host females may face serious risks, including death. 114
Researchers are also concerned about the impact that the aging
process will have on these cloned animals. 115 Cells are capable of a
finite number of divisions. 116 Scientists are unsure what effect the aged
nucleus has on these cloned animals. 117 Studies have shown that cloned
animals die faster and are unhealthy in most cases. 118 Scientists are also
concerned about whether these cells will mutate, thus giving rise to
health problems, like cancer, in their offsprings. 119 In fact, Dolly, the
celebrity sheep, lived to the age of 6. 120 She was put down by lethal
injection in 2003 because she had been suffering from lung cancer and
crippling arthritis. 121 Although Dolly's postmortem examination

105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115 .
116.
117.
118.
119.
120.
121.

Human Genome Project Information, supra note 84.
Id.
National Human Genome Research Institute, supra note 56.
Human Genome Project Information, supra note 84.
Id.
Id.
Id.
Id.
Human Genome Project Information, supra note 84.
Id.
National Human Genome Research Institute, supra note 56.
Id.
Id.
Id.
Id.
Human Genome Project Information, supra note 84.
Id.
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indicated that, other than the cancer and arthritis, she was quite normal,
most Finn Dorset sheep live to be 11 to 12 years of age. 122
Most of the ethical objections to reproductive cloning are
expressed in "playing God" arguments. 123 Opponents believe that
researchers are upsetting the natural balance to life and that reproductive
cloning would rob "a future individual of the right to a unique
identity." 124 Interestingly, much of this concern regarding reproductive
cloning is based on the public's misperception that a child can be
created who would be identical to an existing person. 125 This fear is
based on the theory of genetic determinism, which states that genes
alone affect who an individual will become. 126 In reality, individuals are
influenced by much more than just their genes. 127 "Each individual is, in
fact, the result of a complex interaction between his or her genes and the
environment within which she or he develops." 128
The strongest argument against reproductive cloning encompasses
familial and child welfare related considerations. 129 Proponents of
reproductive cloning advertise the potential use of this procedure to
provide couples, who could not normally have children, with an
offspring clone carrying one of his or her parent's genes. 13 Critics,
though, argue that cloning would lead to ambiguous familial
relationships. 131 They argue that "[i]f the cell nucleus from the father
were used, for example, the child would be the genetic son of its
grandparents, the genetic sibling of its uncles and aunts and the genetic
uncle of its cousins." 132 Furthermore, the situation becomes even more
convoluted when parents want to replace a dead child with a clone. 133
Since both the genes and the environment shape a child's development,
the clone would not be identical to the dead child. 134 Serious

°

122. Human Genome Project Information, supra note 84.
123. National Human Genome Research Institute, supra note 56.
124. Id.
125. Id.
126. Id.
127. Id.
128. National Human Genome Research Institute, supra note 56.
129. The United Kingdom Parliament, House of Lords Stem Cell Research Report,
Appendix 6.6, at http://www.publications.parliament.uk/pa/ld200102/ldselect/ldstem/83/
8316.htm (last visited Nov. 13, 2004).
130. Id.
131. Id.
132. Id.
133. Id. at Appendix 6.7.
134. National Human Genome Research Institute, supra note 56.
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repercussions are likely to emerge in such situations. 135 Parents, who
expected to merely substitute the clone for their dead child, may be
disappointed. 136 The cloned child, meanwhile, "would have to live with
the unavoidable [fact] that it was intended to replace a lost child and
was not brought into being for its own sake." 137
This lack of understanding about reproductive cloning, coupled
with the scientific uncertainties surrounding thes~ experiments, have
prompted most people to conclude that it would be unethical to create
human clones at this point in time. 138

G.

Description of Therapeutic Cloning

Therapeutic cloning, on the other hand, is very different from
reproductive cloning. 139 Therapeutic cloning, or embryo cloning, is the
production of embryos for research. 140 The purpose of this research is to
create embryos that grow to the blastocyst stage so that human
embryonic stem cells can be extracted and used for developing
therapies and treatments for human ailments. 141 Reproductive cloning,
in contrast, would take the next step and actually implant the blastocysts
in women's uteruses with the goal of creating babies.1 42 Thus, the
purposes of reproductive cloning and therapeutic cloning are very
different. 143
Human embryonic stem cells derived from cloned embryos would
have the greatest potential to improve organ transplants. 144 As
previously discussed, researchers were concerned that patients' immune
systems would still reject a donor's embryonic stem cells. 145 If cloned
cells were used, that risk would be greatly diminished. 146
In November 2001, scientists from a biotechnology company in
Massachusetts cloned the first human embryos for research. 1 7 They

135. The United Kingdom Parliament, supra note 129, at Appendix 6.7.
136. Id.
137. Id.
138. The United Kingdom Parliament, supra note 129; Human Genome Project
Information, supra note 84; National Human Genome Research Institute, supra note 56.
139. Human Genome Project Information, supra note 84.
140. Id.
141. Id.
142. Id.
143. Id.
144. Human Genome Project Information, supra note 84.
145. Id.
146. Id.
147. Id.
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took eggs from women's ovaries. 148 Next, they removed the nuclei from
those eggs and replaced them with skin cells. 149 Despite the limited
results from this experiment, the potential use of cloned embryos as a
source of embryonic cells can be a safe and acceptable alternative to
current practices that can involve the use of cells extracted from aborted
and stillborn fetuses. 150
H.

Objections to Therapeutic Cloning

Opponents of therapeutic cloning object to this procedure for
several reasons. 151 First, opponents assert that embryos should not be
created solely for research purposes. 152 Second, opponents argue that
therapeutic cloning is "a step on the slippery slope to 'reproductive
cloning. "' 153 Third, researchers have to battle opposition directed at
therapeutic cloning because of the public's lack of knowledge about the
fundamental differences between reproductive and therapeutic
procedures. 154 "The difficulty in making a distinction between
reproductive and therapeutic cloning is showing up most evidently in
two competing Senate bills." 155 In 2003, Senate Majority Leader Bill
Frist proposed a bill that would ban all forms of cloning. 156 The other
bill, in contrast, banned reproductive cloning, while it allowed
therapeutic cloning. 157
It appears that there is often some degree of stigma attached to any
cloning procedure, regardless whether its goal is to create baby clones
or to extract human stem cells for therapeutic purposes. 158 Scientists
were quick to denounce the announcement made in early 2003 by a
religious Sect, the Raelians, that they had created the first human
clone. 159 The group failed to provide any evidence in support of its
claim and researchers in favor of therapeutic cloning were afraid that
they would be unfairly lumped together with scientists who were

148.
149.
150.
151.
152.
153.
154.
A17.
155.
156.
157.
158.
at 7.
159.

Human Genome Project Information, supra note 84.
Id.
Id.
The United Kingdom Parliament, supra note 129, at§ 5.5.
Id.
Id.
Gregory E. Kaebnick, All Clones are Not the Same, N.Y. TIMES, Jan. 2, 2003, at

Id.
Id.
Id.
Gina Kolata, The Promise of Therapeutic Cloning, N.Y. TIMES, Jan. 5, 2003, § 4,
Id.
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carrying out reproductive cloning experiments. 160 Scientists want to be
clear that the Raelians were not engaging in therapeutic cloning
research. 161 They declared that "[w]hat [the Raelians] said [they] did is
reproductive cloning, which creates humans but has no role in curing
disease." 162 They also exhorted the scientific community to "plead with
the public, [to avoid being tarred] with the same brush." 163 Scientists are
fearful that therapeutic research will continue to suffer setbacks unless
the public becomes aware of the fundamental differences in these two
types of cloning procedures. 164
In November 2003, the New York Times reported that President
Bush was supporting a United Nations proposal banning all types of
cloning, including therapeutic cloning. 165 There were three competing
resolutions and the U.S. 's position, while by far the most extreme, was
backed by more than 100 countries. 166 Belgium advanced a more
moderate proposal, banning only reproductive cloning, not therapeutic
cloning. 16 This second plan was supported . by approximately 20
countries. 168 Even though the U.N. has no authority to ban research
itself, the nations that sign a treaty are expected to adhere to it. 169 The
U.S. supports the position that a partial ban would "leave open the door
to abuses, with the emer~ence of a black market in embryos provided by
impoverished women." 1 0 Researchers, however, argue that a total ban
would deprive signatory countries from reaping the benefits of
therapeutic cloning procedures that are much less controversial and
risky than reproductive cloning techniques since embryos are created in
a lab, outside of women's uteruses. 171 The "U.S.-led drive for a broad
global ban on all forms of human cloning" was eventually blocked by
the U.N. general assembly's legal committee, which voted 80 to 79,
with 15 abstentions, to defer drafting the treaty until 2005. 172

160. Kolata, supra note 158.
161. Id.
162. Id.
163. Id.
164. Id.
165. A Fight at the UN. Over Cloning, N.Y. TIMES, Nov. 5, 2003, at A24; Semple,
supra note 94.
166. Semple, supra note 94.
167. Id.
168. Id.
169. Id.
170. Id.
171. National Human Genome Research Institute, supra note 56.
172. Irwin Arieff, US Loses UN Vote on All-Out Cloning Ban, THE GUARDIAN, Nov. 7,
2003, available at http://www.guardian.co.uk/intemational/story/0,3604,1079871,00.html
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U.S. Regulations on Cloning

The U.S. House of Representatives voted 265 to 162 in July 2001
to make any form of cloning a criminal offense. 173 One year later,
President Bush announced his policy to restrict government funds to
research involving preexisting embryonic stem cell lines. 174 Current
bills before Congress vary from conservative versions prohibiting all
types of cloning, like the Frist proposal, to moderate versions
prohibiting reproductive cloning and imposing a moratorium on
therapeutic cloning, to the most liberal proposal prohibiting
reproductive cloning while permiting therapeutic cloning. 175 Currently,
the Senate has not taken any action, and researchers expect the President
to announce a moderate plan, which would prohibit reproductive
cloning and impose a moratorium on therapeutic cloning. 176
Gregory E. Kaebnick, a bioethics research associate at The
Hastings Center wrote, "Distinctions that require explanations tend to
get lost in public debate, and the controversy over cloning is a perfect
example. There are two fundamentally different types of cloningreproductive cloning and therapeutic cloning-but the distinction
between them is in danger of getting lost. And if it does, it could be a
severe blow to science." 177 Time will reveal whether or not researchers
in the genetics field will be able to overcome the public's misperception
of therapeutic cloning and convince legislators to permit this procedure.
Otherwise, scientists will be unable to realize the full potential of human
embryonic stem cell research. 178
II.

U.K. REGULATORY SCHEME REGARDING EMBRYONIC STEM CELL
RESEARCH AND THERAPEUTIC CLONING

A.

Introduction

The U .K.' s approach to human embryonic stem cell research and
therapeutic cloning has evolved with emerging technologies and, as a
result, has enabled that country to take advantage of these new fields of
research while staying in tune with its citizenry. 179 The British

(last visited Nov. 13, 2004).
173. National Human Genome Research Institute, supra note 56.
174. Id.
175. Id.
176. Id.
177. K.aebnick, supra note 154.
178. Id.
179. See generally The United Kingdom Parliament, supra note 129.
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Parliament appointed the Wamock Committee [hereinafter the
Committee] to report its findings about the ethics of human embryonic
stem cell research. 180 The Committee started by considering what status
should be granted to an early embryo. 181 The Committee "adopted a
position between these opposing views, concluding that the early
embryo has a special status but not one that justifies its being accorded
absolute protection." 182 This view was reflected in the Human
Fertilization and Embryology Act of 1990 [hereinafter the 1990 Act]
that the Parliament eventually adopted. 183
B.

Warnock Committee Defines Status of an Early Embryo

The Committee first reasoned that persons must be respected so
they cannot be treated as mere means. 184 The Committee attempted to
accommodate various competing interests, including religious
organizations, right-to-life advocates, members of the scientific
community as well as many other groups. 185
The Committee considered the basic arguments that right-to-life
advocates assert. People who advocate that embryos also deserve the
same protection that persons receive rely on the fact that embryos have
the potential to become persons. 186 It seems to follow, according to
proponents of this gosition, that the embryo is alive and must therefore
have a right to life. 87
The Committee, on the other hand, took into account arjuments
that embryos should not share the same status as persons. 1 8 First,
babies have a "continuity of identity," between the baby and the adult it
will one day become. 189 An embryo, meanwhile, does not have that
same continuity. 190 A blastocyst can become a heart or an umbilical
cord or divide to form twins. 19 r
Second, the embryo, on its own, cannot survive. 192 "Although the

180.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.

The United Kingdom Parliament, supra note 129, at§ 4.
Id. at§ 4.5.
Id.
The United Kingdom Parliament, supra note 129, at§ 4.5.
Id. at§ 4.7.
Id. at§§ 4, 5.
Id. at§ 4.9.
Id.
The United Kingdom Parliament, supra note 129, at§ 4.21.
Id. at§ 4.9.
Id. at§ 4.11.
Id. at§ 4.11.
Id.
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early embryo contains within it the full genetic potential of one or
several human beings who may develop from it, it requires many other
factors, particularly those provided by the maternal environment in the
womb, to enable it to realise that potential." 193 Embryos, like tissues and
cells are technically alive, but being alive does not necessarily mean an
embryo is afforded a full right to life. 194
Third, the Committee weighed in on the reaction that cultures have
when an early embryo is lost. 195 It stated that "[a]lthough would-be
parents may feel sad at the natural loss of early embryos before
implantation, there is no public mourning ritual associated with it, nor is
there for the loss of surplus embryos left over from IVF treatments." 196
Fourth, the Committee evaluated current British legislation
directed at research on human embryos. 197 Abortion has been legal for
over 30 years in the U .K. 198 The Abortion Act permits the termination
of pregnancies where fetuses are 24 weeks or less. 199 This legislation
"reflects a gradation in the respect accorded . to a fetus as it develops
from the early embryo to its birth."200 This law seems to echo the
majority opinion. In addition, in vitro fertilization has been used for 25
years and has garnered much public support. 201 Since there is no way to
avoid the creation of surplus embryos, some will be destroyed. 202 The
Committee therefore concluded that "[t]o accord the early embryo the
full protection accorded to a person would also be inconsistent with the
use of IVF. " 203
Finally, there are many advocates who argue that the benefits of
embryonic stem cell research and therapeutic cloning outweigh the evil
of destroying embryos. 204 These procedures have the potential to treat
many serious illnesses. 205 It follows that "respect for persons may take
the form of developing treatments for serious degenerative diseases, and
there can be few causes more worthwhile than to relieve the suffering

193.
194.
195.
196.
197.
198.
199.
200.
201.
202.
203.
204.
205.

The United Kingdom Parliament, supra note 129, at§ 4.11.
Id. at§ 4.14.
The United Kingdom Parliament, supra note 129 at§ 4.13.
Id. at§ 4.13.
Id. at § 4.20.
Id.
Id. at § 4.20.
The United Kingdom Parliament, supra note 129, at§ 4.20.
Id.
Id.
Id.
Id. at§ 4.17.
The United Kingdom Parliament, supra note 129, at§ 4.17.
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caused by the diseases. " 206 Although the Committee gives preference to
embryos extracted from surplus embryos from in vitro fertilization
procedures, the 1990 Act allows for the creation of embryos specifically
for research purposes when "there is a demonstrable and exceptional
need." 207 Thus, the Committee concluded that an embryo should have
the status of a potential person, but they would not grant embryos an
unconditional claim to protection since embryonic cells have the
potential to facilitate so many important treatments. 208

C.

Human Fertilization and Embryology Act of 1990

The Committee's report led to the 1990 Act that is still relevant
and supported by the majority of British citizens. 209 The Act requires
that a fourteen-day limit from the time the embryo begins to develop be
imposed on embryonic research. 210 This is because "[f]ourteen days has
an objective justification insofar as it represents the stage at which the
primitive streak, the precursor of the development of a nervous system,
begins to appear. " 211 The Act requires informed consent from the
donors, outlaws payment for donations, places restrictions on the export
of the embryos, and requires meticulous record-keeping to account for
the creation and disposal of embryos. 212
The U .K. regulatory scheme also established The Human
Fertilisation and Embryology Authority (HFEA) to oversee the use of
embryonic cells. 213 The HFEA has been successful because it has
commandeered respect from both the medical and scientific
communities, as well as the British citizenry. 214 The HFEA uses experts
in the field to peer-review applications to ensure that the proposed use
of embryos is in accordance with legislative requirements. 215 The HFEA
then grants licenses to scientists to engage in embryonic stem cell
research. 216 This agency also controls the development of new stem cell
lines when it is satisfied that there are no suitable existing cell lines. 217

206.
207.
208.
209.
210.
211.
212.
213.
214.
215.
216.
217.

The United Kingdom Parliament, supra note 129, at § 4.17.
Id.
Id. at § 4.28.
Id. at §4.20.
Id. at § 4.22.

The United Kingdom Parliament, supra note 129, at§ 4.20.
4.25.
8.
8.1.
8.2.
The United Kingdom Parliament, supra note 129, at§ 8.6.
Id. at § 4.
Id. at§
Id. at§
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Moreover, the HFEA worked with the British Department of Health and
the Medical Research Council (MRC) to establish an embryonic stem
cell bank to ensure the purity of these cells and to develop codes of
conduct for the use of the bank. 218
D.

U.K. Restrictions on Reproductive and Therapeutic Cloning

In 2001, the British Parliament issued additional regulations under
the Human Fertilization and Embryology Act of 1990 to address
cloning. 219 The Parliament took into account the same factors that were
present in the human embryonic stem cell research debate and
concluded that therapeutic cloning should be permitted and reproductive
cloning should be banned. 220
The Parliament decided to address the two types of cloning in
separate pieces of legislation. 221 First, the government passed the
Human Reproductive Cloning Act of 2001 that banned reproductive
cloning. 222 This law makes it a criminal offense for researchers to
transplant a cloned embryo into a woman's uterus. 223
Meanwhile, the Parliament had merely extended the 1990
Embryology Act to include therapeutic cloning. 224 This decision was
met by much criticism. 225 Opponents of the 1990 Act argue that it
should not be used to regulate therapeutic cloning because the
legislation made no mention of cloning or cell nuclear transfers
(CNR).226
The Parliament countered by stating that it extended the 1990 Act
with the 2001 Regulations because the inclusion of therapeutic cloning
aligned with the original purpose of the law. 227 The government
reasoned that ten years ago researchers believed that cell nuclear
replacement only had application in reproductive cloning. 228 Now
scientists realize that this technique has application in therapeutic

218.
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220.
220.
221.
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225.
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The United Kingdom Parliament, supra note 129, at§§ 8.26, 8.27.
Id. at§ 5.1.
Id. at § 8.
Id.
Id.
The United Kingdom Parliament, supra note 129, at§ 8.16.
Id. at§ 8.16.
Id. at § 5.4.
Id. at § 5.5.
Id. at§ 5.1.
The United Kingdom Parliament, supra note 129, at§ 5.4.
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cloning. 229 The British government weighed the same factors that were
present in the human embryonic stem cell research debate and
concluded that the benefits of therapeutic cloning outweigh the ethical
problems associated with this procedure. 230 Thus, the government
imposed strict guidelines to limit the creation of cloned embryos to
situations where "there is a demonstrable and exceEtional need which
cannot be met by the use of surplus embryos." 31 The Parliament
concluded that therapeutic cloning is a vital research tool for scientists
to further human embryonic stem cell research and, as a result, extended
the 1990 Act to allow for this type ofprocedure. 232
Even though the British Parliament has passed more legislation
than the U.S. to regulate the use of embryonic cells, the U.K. maintains
a much more open-minded approach to these controversial
procedures. 233 In providing public funding, the British government has
the luxury of installing an agency to oversee the use of embryos while
being able to require meticulous record-keeping by researchers to
account for every embryo. 234 The U.K. system is both well-managed
and supportive, thus granting British citizens access to the benefits of
embryonic stem cell research and therapeutic cloning. 235
III. UNREGULATED, PRIVATE GENETIC RESEARCH IN THE U.S.

A.

Introduction

The U.S. government needs to adopt an approach similar to the
U .K.' s regulatory scheme in order to reap the potential benefits of
human embryonic stem cell research and therapeutic cloning. The U.S.
government has been too restrictive with appropriations of government
funds for human embryonic stem cell research and therapeutic
cloning. 236 At the same time, the government has so far provided only
minimal guidelines for private research. 237
Since the private research sector is largely unregulated, the
government has essentially turned its back to the consequences of
procedures that use human embryonic stem cells, which may challenge
229.
230.
231.
232.
233.
234.
235.
236.
237.

The United Kingdom Parliament, supra note 129, at§ 5.9.
Id. at § 5.4
Id. at§ 5.14.
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Id. at § 8.
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White House Press Release, supra note 85.
Id.

https://surface.syr.edu/jilc/vol32/iss1/5

22

Burchell: America's Struggle To Develop A Consistent Legal Approach To Cont

2004]

Embryonic Stem Cell Research

155

what society is capable of tolerating at this time. A British online
magazine included an editorial piece in 2003 that told the story of two
brothers, Jamie and Charlie Whitaker. 238 Charlie is five-years old and
suffers from a rare blood disorder that requires him to undergo painful
blood transfusions and injections. 239 A promising treatment requires the
transfusion of blood stem cells taken from an umbilical cord of a baby
with a matching tissue type. 240
Charlie's parents decided to have Jamie, a "saviour sibling," serve
as a tissue match for his big brother. 241 Jamie was conceived via a
process of fertilization, genetic testing and selection of embryos prior to
pregnancy to ensure the likelihood that his tissue would be compatible
with his older brother's. 242 This process is also referred to as designing
babies. The boys' mother says that the family "combined having more
[children] with helping Charlie. " 243
The British family turned to a Chicago clinic for help after the
HFEA decided it would not grant the Whitakers permission to use in
vitro fertilization and genetic testing since Charlie's condition was not
known to be significantly influenced by genetic factors. 244 The British
agency concluded that "[i]f there are benefits for the child to be created
from a [tested] embryo ... to avoid significant risk of serious disease,
then. . .the balance of potential harm and potential good falls in a
different place than if you are simply [testing] an embryo for the benefit
of another person. " 245 Even though the HFEA came under fire for not
helping Charlie, the agency concluded that the risks were too great in
this instance. 246 Furthermore, the agency felt that the process may be
beyond what the British public will tolerate at that time. 247
Therefore, the family set its sights on America where private sector
scientists were willing to make this controversial leap. 248 So it happened
that "the much-maligned American private sector, and a specific
Chicago clinic in particular, ... stepped in where others in the U.K.

238. John Gillott, !VF babies: Life Chances, Spiked Science, at http://www.spikedonline.com/Articles/00000006DE17.htm (last visited Nov. 13, 2004).
239. Id.
240. Id.
241 . Gillot, supra note 238
242. Id.
243. Id.
244. Id.
245. Id.
Gillot, supra note 238.
247. Id.
248. Id.
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either could not or would not. " 249 Since there are no laws restricting
these human embryonic stem cell procedures in the private sector, no
one stopped to involve the American citizenry in the public debate. No
one discussed whether or not "designing" Jamie was too risky and
whether or not the procedure went beyond the limits of what Americans
are willing to tolerate.

B.

Discussion of Techniques for Designing Babies

There are several different techniques for designing babies. 250
Some techniques serve important medical purposes. 251 First, embryos
can be screened where the likelihood is high that an offspring will have
a serious genetic disease. 252 Embryos that have the inherited condition
are not implanted in the womb. 253 Second, embryos can also be
screened for unknown diseases. 254 Again, only the healthy embryos are
implanted. 255 Third, embryos can be screened to select the sex of a baby
to prevent certain diseases that are only passed through the male line or
the female line. 256
Other, more controversial, techniques may also be possible in the
future. 257 Scientists hope to one day fix defective or diseased embryos
when they are at an early stage. 258 Therapeutic cloning could be utilized
to replace a cell's defective DNA with healthy DNA. 259 This technique
has not been carried out on humans yet. 260 An even more controversial
technique would allow doctors to create a genetic profile for each
embryo and parents could then select an embryo based on that profile. 261
This technique has no therapeutic value, but it is also not possible right
now. 262 Perhaps the most controversial techniaue involves the genetic
manipulation of embryos for cosmetic reasons. 2 3 In the future it may be

249. Gillot, supra note 238.
250. Center for the Study of Technology and Society, Special Focus- Designer Babies,
http://www.tecsoc.org/biotech/focusbabies.htm (last visited Nov 13, 2004).
251. Center for the Study of Technology and Society, supra note 250.
252. Id.
253. Id.
254. Id.
255. Id.
256. Center for the Study of Technology and Society, supra note 250.
257. Id.
258. Id.
259. Id.
260. Id.
261. Center for the Study of Technology and Society, supra note 250.
262. Id.
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possible for parents to choose the eye color, hair color, and height of
their offspring. 264 Scientists point out, though, that other characteristics
such as intelligence, athleticism, and beauty are ultimately determined
by a child's environment, thus minimizing the effect of genetic
manipulation on the development of the human being. 265

C.

Objections to Designing Babies

The basic arguments against "designing babies" involve the
"looming shadow of eugenics- the practice of 'improving' the human
gene pool by eliminating undesirables."266 Critics assert that tampering
with early embryos and stem cells may actually bring about unintended
mutations to the gene pool. 267 Furthermore, opponents state that it is
unethical to treat an embryo as a means to parents' happiness. 268
Likewise, economic pressures may be a factor when parents make
design choices because "[i]nsurance companies, for instance, may
refuse to cover a newborn with a condition that could have been
corrected before birth, thus, forcing parents to design their child. " 269
Another major social concern is that these designing techniques
will lead to a race of super humans who could discriminate against
others without genetic enhancements. 270 Moreover, if these techniques
are only available to the wealthy, the poor will be left to suffer through
these inherited ailments. 271 Finally, many of these techniques can lead to
the destruction of embryos either inside or outside a woman's womb,
which is anathema to anti-abortion advocates. 272

D.

Implications of "Designing Techniques"

In a related story, the New York Times printed repeated ads for the
Genetics and IVF Institute (GIVF) that openly marketed a eugenics
procedure to let parents select the sex of their baby. 273 The ad offers the
sex-selection procedure as a method of "balancing" the makeup of a

264.
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Center for the Study of Technology and Society, supra note 250.
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Center for the Study of Technology and Society, supra note 250.
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273. Austin Ruse, New York Times Ads Offer Designer Babies, Wed., Oct. 8, 2003,
N ewsMax.com, at http://www.newsmax.com/archives/articles/2003/ 10/8/23 812.shtml (last
visited on Nov. 13, 2004).
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family and allow for treatment of babies with gender-linked health
problems. 274 The article also reported that in the U.K. there have been
cases where mothers of babies with Down syndrome or simply
surgically correctable ailments have been pressured by doctors "to abort
their babies for the greater good of society. ,ms
Opponents of this genetic testing procedure are hoping that
legislators will take their warnings as a wakeup call. 276 Bill Albert,
member of the Council of Disabled People, says that Americans need to
"face up to what's going on and not say this is about choice [since] this
is [really] about elimination. " 277 Opponents believe that desiwing
techniques would wipe out the disabled portion of our population. 2 8
The novelty of these designing procedures and the public's lack of
awareness have permitted private sector scientists to slip under the radar
of government regulation. Since the U.S. does not have a strong
regulatory structure in place to deal with embryonic stem cell research
and therapeutic cloning, especially in the private sector, scientists may
view the government's hands-off approach a license to run free with
emerging techniques. Leslie Bender, an Associate Dean and Professor
of Law and Women's Studies at Syracuse University College of Law,
advocated in a journal article that the U.S. legislature needs to address
these new reproductive techniques because the courts have been forced
to settle disputes where there is little or no legal or Eolicy guidance,
resulting in frequent mistakes by the judiciary. 79 Researchers,
meanwhile, are fearful that legislators will eventually react to these
radical procedures and, without drawing distinctions between the
various uses of embryos, will institute a complete ban or moratorium. 280
IV. THE U.S. SHOULD ADOPT BRITAIN'S REGULATORY APPROACH TO
HUMAN EMBRYONIC STEM CELL RESEARCH AND THERAPEUTIC CLONING
Thirty years after Roe v. Wade, 281 the U.S. has failed to come to
terms with the debate over the legal status of an embryo. 282 Abortion is
still a politically divisive issue in America, and it is unlikely that

274. Ruse, supra note 273.
275. Id.
276. Id.
277. Id.
278. Id.
279. Leslie Bender, Genes, Parents, and Assisted Reproductive Technologies: ARTs,
Mistakes, Sex, Race, & Law, 12 COLUM. J. GENDER& L. l, 13-14, 74-75 (2003).
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Congress will resolve it any time soon. 283 Most opposition to the use of
embryonic cells in the U.S. revolves around "religious and ethical
principles [that] play an influential role in lawmaking."284
The U.K., meanwhile, has adopted the view that it is difficult to
justify an absolute prohibition on the destruction of early embryos while
permitting abortion after a fetus has begun to develop. 285 In addition, the
British Parliament relies on the fact that the majority of its citizens
support embryonic stem cell research and therapeutic cloning. The
U.K., through careful consideration and strict regulation, has been able
to find an appropriate middle ground.
The U.S. government; however, has not been as successful at
finding a consistent approach. On the one hand, the government has
been too conservative in providing federal funds for embryonic
research, mostly due to misunderstanding and blurry distinctions
between embryonic stem cell procedures. On the other hand, the U.S.
government has been too liberal in not providing more restrictions on
private sector embryonic research. Another important challenge facing
American legislators is the difficulty in transforming healthcare system
to enable healthcare organizations to incorporate these new
technologies.
Before his death, Christopher Reeve, the actor-turned-patient and
advocate for embryonic stem cell research, gave a talk that cited polls
showing 68 percent of Americans actually support all types of
embryonic stem cell research. 286 In 1995, Reeve was injured in a horse
riding accident that left him paralyzed. 287 He warned that politics in the
U.S. were getting in the way of patient hope, claiming the U.S.
government had become a roadblock between the American people and
the life-saving therapies and treatments that resulted from embryonic
cells. 288 He stated that countries, like the U.K., have "purified
embryonic stem cell lines, ready for export around the world," and that
the U.S. "must reclaim [her] preeminence."289
Without adequate federal funding there is a danger that U.S.
academic researchers will leave and go to other countries to conduct
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their research. 290
The economic reality is that "[a]lthough the
biotechnology industry has noble goals, it is profit driven." 291 Not only
will these other countries benefit from the contributions made by U.S.
researchers, but they will also benefit economically when the U.S. is
forced to pay for the use of their stem cell lines. 292
It seems that the U.S. has no choice but to provide federal funds
and put in place a regulatory structure aimed at a controlled facilitation
of the use of embryonic cells. Recently, South Korean scientists
announced that they successfully cloned human embryos extracted from
embryonic stem cells and derived from eggs donated by Korean
women. 293 The U.S. needs to come to terms with the use of embryonic
stem cells or, otherwise, the U.S. will lose its preeminence in the
scientific arena, the American public will lose out on the potential
benefits of embryonic stem cell research and therapeutic cloning, and
private sector scientists will continue to utilize genetic testing
procedures that are out of sync with American values.
Regardless of how the U.S. government chooses to approach the
use of embryonic cells, it is clear that a hands-off approach will not be
tolerated for much longer as new techniques are rapidly emerging. In
addition, the aging Congress continues to make proposals that federal
monies should be used to fund embryonic stem cell research. 294
Congress may one day override the President's current prohibitory
policy. 295 Also, states may continue to pass their own laws and, as a
result, trigger the national government to reevaluate its own regulatory
scheme. 296 New Jersey and California lawmakers recently passed
legislation that made a "powerful statement against federal funding
restrictions on such research."297 Furthermore, inconsistent and vague
state laws may also prompt the federal government to pass uniform
national laws. 298 Once the U.S. government takes another stab at
passing regulations concerning embryonic stem cell research and
therapeutic cloning, it would be in the interest of all Americans if our
legislators and President used the U .K. 's regulatory scheme as a model.
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CONCLUSION

Even though the U .K. has codified more rules on embryonic stem
cell research and therapeutic cloning than the U.S., "these regulations
reflect a more permissive attitude toward conducting and funding
research."299 President Bush's policy restricting federal funding for
these types of research has made it impossible for the NIH to develop
guidelines that "promote medical advancements and appropriately limit
research under the authority of a conflicted federal government. " 300
Congress, the President, and the American public lack enough
information to make informed decisions and to distinguish beneficial
therapies from those procedures that are considered too controversial.
Consequently, the U.S. fails to make any significant breakthroughs in
the fight against potential diseases and in the search reproductive
treatments to be derived from embryonic stem cell research and
therapeutic cloning.
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